Quarterly report pursuant to Section 13 or 15(d)

Note 1 - History and Basis of Presentation: Income/loss Per Common Share: Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Tables)

v2.4.1.9
Note 1 - History and Basis of Presentation: Income/loss Per Common Share: Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Tables)
9 Months Ended
Sep. 30, 2014
Tables/Schedules  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

 

September 30,

 

2014

2013

 

 

 

Convertible notes

18,900,000

18,900,000

Convertible preferred stock - Series B

11,818,181

11,818,181

Warrants

3,083,332

24,585,662

Compensation-based stock options and warrants

43,576,243

69,208,483

 

77,377,756

124,512,326